Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2024-09-04 00:00:00 ET · period of report 2024-07-15 · accession 0001415889-24-022861 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-09-04 | 2024-09-01+ | KNSA | Megna Michael R | CAO | M - OptEx | — | +7,265 | 26.8K | +37% | — |
| D | 2024-09-04 | 2024-07-15 | KNSA | Megna Michael R | CAO | A - Grant | $15.65 | +480 | 22.3K | +2% | +$7,512 |
| DM | 2024-09-04 | 2024-09-01+ | KNSA | Megna Michael R | CAO | F - Tax | $26.74 | -3,084 | 26.0K | -11% | -$82.5K |
| DM | 2024-09-04 | 2024-09-01 | KNSA | Megna Michael R | CAO | A - Grant | $0.00 | +28.4K | 18.9K | New | $0 |
| DM | 2024-09-04 | 2024-09-01+ | KNSA | Megna Michael R | CAO | M - OptEx | $0.00 | -7,265 | 7,865 | -48% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2024-09-01 | M | A | 6,490 | — | 28,744 | D | — | — | (F2) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. |
| 2 | Common | Class A Ordinary Share | 2024-09-02 | M | A | 775 | — | 26,764 | D | — | — | (F2) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. |
| 3 | Common | Class A Ordinary Share | 2024-07-15 | A | A | 480 | $15.65 | 22,254 | D | — | — | |
| 4 | Common | Class A Ordinary Share | 2024-09-02 | F | D | 329 | $26.74 | 26,435 | D | — | — | |
| 5 | Common | Class A Ordinary Share | 2024-09-01 | F | D | 2,755 | $26.74 | 25,989 | D | — | — | |
| 6 | Derivative | Restricted Share Unit | 2024-09-01 | A | A | 9,450 | $0.00 | 9,450 | D | — · — to — | 9,450 Class A Ordinary Share | (F2) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. (F3) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date, September 1, 2024. |
| 7 | Derivative | Share Option | 2024-09-01 | A | A | 18,900 | $0.00 | 18,900 | D | $26.74 · — to 2034-08-31 | 18,900 Class A Ordinary Share | (F4) The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2024. |
| 8 | Derivative | Restricted Share Unit | 2024-09-02 | M | D | 775 | $0.00 | 774 | D | — · — to — | 775 Class A Ordinary Share | (F2) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. (F7) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 2, 2021. |
| 9 | Derivative | Restricted Share Unit | 2024-09-01 | M | D | 2,558 | $0.00 | 7,672 | D | — · — to — | 2,558 Class A Ordinary Share | (F2) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. (F6) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2023. |
| 10 | Derivative | Restricted Share Unit | 2024-09-01 | M | D | 3,932 | $0.00 | 7,865 | D | — · — to — | 3,932 Class A Ordinary Share | (F2) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. (F5) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2022. |